Scientists have developed a gel-based version of semaglutide that could reduce how often people need to take it.

French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and ...

Innovative semaglutide hydrogel may revolutionize diabetes treatment by reducing the need for injections to just once a month ...

A recent announcement by Eli Lilly suggests that the company understands the economic conundrum some patients face. Per a ...

GLP-1 drugs such as Ozempic and Wegovy are booming among consumers. That means Americans are downsizing in fitting rooms and grocery aisles.

GlobalData’s report assesses the drugs in the Glucagon Like Peptide 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GLP-1 agonists may improve the disease course for a host of neurological and psychiatric disorders tied to inflammation, ...

In a recent article published in Science, researchers reviewed clinical studies on the advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control. GLP-1 medications ...

Eli Lilly's experimental next generation weight-loss drug mimics three hormones instead of just one or two and continues to ...

In people with diabetes, the "oatzempic" online diet fad may lead to increased glucose, decreased muscle mass, and ...

New STEP-HFpEF findings presented at this year’s European Society of Cardiology Congress add to the many accolades this ...

A recent study found that over four years, participants taking Wevovy as indicated experienced an average weight loss of 10.2 ...